Floatz logo

588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Basiliximab
Acute Myeloid Leukemia
City of Hope Medical CenterP2B (57)
Dfp-10917
Acute Myeloid Leukemia
Delta-Fly Pharma, Inc.P3B (57)
Fluconazole
Acute Myeloid Leukemia
Bochud Pierre-YvesP3B (57)
Hht
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (57)
Itraconazole
Acute Myeloid Leukemia
Mansoura UniversityP2B (57)
Nadravaleucel
Acute Myeloid Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2B (57)
Uproleselan
Acute Myeloid Leukemia
National Cancer Institute (NCI)P3B (57)
Ventoclax
Acute Myeloid Leukemia
Guangdong Second Provincial General HospitalP2/3B (57)
Carboplatin
Acute Myeloid Leukemia
Joanna YiP2B (56)
Ciml-Nk Cells
Acute Myeloid Leukemia
Children's Hospital Medical Center, CincinnatiP2B (56)
Diphenhydramine
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP2B (56)
her2bbζ/cd19t+ t cells
Acute Myeloid Leukemia
David AviganP1/2B (56)
Imgn632
Acute Myeloid Leukemia
AbbVieP2/3B (56)
L-Ofloxacin
Acute Myeloid Leukemia
University of ManitobaP3B (56)
Prednisolone
Acute Myeloid Leukemia
Children's Oncology GroupP2B (56)
Ruxolitinib Phosphate
Acute Myeloid Leukemia
City of Hope Medical CenterP2B (56)
Tagraxofusp
Acute Myeloid Leukemia
Jacqueline Garcia, MDP2B (56)
Vyxeos
Acute Myeloid Leukemia
Jazz PharmaceuticalsP2/3B (56)
Allopurinol
Acute Myeloid Leukemia
OHSU Knight Cancer InstituteP2CCC (55)
Alpha-Interferon
Acute Myeloid Leukemia
Peking University People's HospitalP4CCC (55)
Eltrombopag
Acute Myeloid Leukemia
French Innovative Leukemia OrganisationP2/3CCC (55)
Hydroxyurea
Acute Myeloid Leukemia
Uma BorateP2CCC (55)
Nogapendekin Alfa Inbakicept
Acute Myeloid Leukemia
Masonic Cancer Center, University of MinnesotaP2CCC (55)
Palbociclib
Acute Myeloid Leukemia
Thomas Jefferson UniversityP1/2CCC (55)
Sitagliptin
Acute Myeloid Leukemia
Indiana UniversityP2CCC (55)
Bleximenib
Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen NederlandP3CCC (54)
Blinatumomab
Acute Myeloid Leukemia
Ascentage Pharma Group Inc.P2CCC (54)
Clifutinib
Acute Myeloid Leukemia
Sunshine Lake Pharma Co., Ltd.P3CCC (54)
Cobicistat
Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen NederlandP2CCC (54)
Cusatuzumab
Acute Myeloid Leukemia
OncoVerity, Inc.P2CCC (54)
Dc/Aml Fusion Vaccine
Acute Myeloid Leukemia
David AviganP2CCC (54)
Emavusertib
Acute Myeloid Leukemia
National Cancer Institute (NCI)P2CCC (54)
Liposomal Cytarabine-Daunorubicin Cpx-351
Acute Myeloid Leukemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.P3CCC (54)
Motixafortide
Acute Myeloid Leukemia
Washington University School of MedicineP2CCC (54)
Nintedanib
Acute Myeloid Leukemia
Northwestern UniversityP2CCC (54)
Azd 5991
Acute Myeloid Leukemia
AstraZenecaP1/2CCC (53)
bp1001
Acute Myeloid Leukemia
Bio-Path Holdings, Inc.P2CCC (53)
Pegfilgrastim
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP2/3CCC (53)
Bl-M11D1
Acute Myeloid Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.P2/3CCC (52)
Decetabine
Acute Myeloid Leukemia
Anhui Provincial HospitalP2CCC (52)
Gardasil 9 Vaccine
Acute Myeloid Leukemia
Vastra Gotaland RegionP2CCC (52)
Hyml-122
Acute Myeloid Leukemia
Tarapeutics Science Inc.P2CCC (52)
Midazolam
Acute Myeloid Leukemia
Novartis PharmaceuticalsP1/2CCC (52)
Nepenthe
Acute Myeloid Leukemia
Peking University People's HospitalP3CCC (52)
Nerofe
Acute Myeloid Leukemia
Immune System Key LtdP2CCC (52)
Qhrd107
Acute Myeloid Leukemia
Changzhou Qianhong Bio-pharma Co., Ltd.P2CCC (52)
Silybin
Acute Myeloid Leukemia
Fujian Medical University Union HospitalP4CCC (52)
Talazoparib
Acute Myeloid Leukemia
German Cancer Research CenterP1/2CCC (52)
Vah
Acute Myeloid Leukemia
Dongguan People's HospitalP2CCC (52)
Zemestosita
Acute Myeloid Leukemia
Liping DouP2CCC (52)
Showing 101 to 150 of 588 assets
PreviousPage 3 of 12Next